Ophthalmology Patient Support Materials
Committed to supporting patient needs
The SmartSight programme provides inspirational, entertaining and educational resources for patients with macular conditions and their loved ones. All materials have been designed by Bayer with the support of the RNIB and the Macular Society.
To order any of the materials listed below and to find out about our support materials for healthcare professionals, please contact the Bayer medical information department on 0118 206 3116, or email medical.information@bayer.co.uk.
SMARTSTART Guides to wAMD, DMO and RVO
Booklets for patients with macular conditions who have been prescribed anti-VEGF therapy. These booklets provide information about the patients' condition and treatment journey. SmartStart guides are recertified for use with original date of preparation.
SmartSight Patient Safety Booklet
A booklet to help people with impaired vision stay safe and look after themselves at home and when out and about. It provides useful tips and ideas of changes to make to help them cope with macular degeneration. Your guide to safe living booklet is recertified for use with original date of preparation.
EYLEA Patient Guides
All patient guides are recertified for use with original date of preparation.
SmartBrowse offers written articles, video content, and audio resources to share inspiring stories and provide practical tips for daily living with visual impairment.
The aim of this tool is to demonstrate, to those with unimpaired vision, the potential of vision loss and the degree of change a person with macular disease may experience. It is for illustrative purposes only and does not serve as a replacement for seeking medical advice.
Abbreviations
BRVO, branch retinal vein occlusion. CRVO, central retinal vein occlusion. DMO, diabetic macular oedema. mCNV, myopic choroidal neovascularisation. RNIB, Royal National Institute of Blind People. ROP, retinopathy of prematurity. RVO, retinal vein occlusion. VEGF, vascular endothelial growth factor. wAMD, wet age-related macular degeneration.
PP-EYL-GB-2368 | August 2024